Search
for
Sort by
Research 181–210 of 1000+
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- Symptom Monitoring and Dependent Care During Cancer Treatment in Children
- JAK Inhibitors for Treatment of Alopecia Areata
- Hair Loss Induced by Tumor Necrosis Factor Alpha Inhibitors
- Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature review
- Conventional and novel stem cell based therapies for androgenic alopecia
- Repurposed Drugs: Current Trends in Drug Discovery
- Platelet-rich plasma therapy: key infection prevention practices and strategies for safety risk reduction
- Alarmin Cytokines as Central Regulators of Cutaneous Immunity
- Cellular and Molecular Mechanisms of Wound Repair: From Biology to Therapeutic Innovation
- Annual Convention in the Time of COVID
- Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
- Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- Hair repigmentation associated with the use of brentuximab
- Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer
- Lipid Profile and 5α-Reductase Inhibition Activity of Proprietary Ultrahigh-Pressure Supercritical Carbon Dioxide and Hexane Saw Palmetto Extracts
- Serenoa repens (Saw palmetto) for Lower Urinary Tract Symptoms (LUTS): The Evidence for Efficacy and Safety of Lipidosterolic Extracts. Part I
- Autoimmune Skin Diseases in the Era of COVID-19: Pathophysiological Insights and Clinical Implications
- Menopause and hair loss in women: Exploring the hormonal transition
- 76708 Risk of Developing Scarring and Non-Scarring Alopecia with GLP-1 and GLP-1/GIP Agonist Utilization
- SnapshotDx Quiz: January 2021
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Thou shall not heal: Overcoming the non-healing behaviour of diabetic foot ulcers by engineering the inflammatory microenvironment
- Inflammatory bowel disease: pathogenesis, diagnosis and current therapeutic approach
- ChatGPT in medicine: Evaluating psoriasis patient concerns
- The association between serum ferritin and 25-hydroxyvitamin D and metabolic syndrome in Korean women: the Korea National Health and Nutrition Examination Survey 2010–2012
- Hidradenitis Suppurativa Tunnels: Unveiling a Unique Disease Entity
- The Relationship Between Mental Health and Drugs used in Dermatology
- No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study